Cor Vasa 2022, 64(6):595-599 | DOI: 10.33678/cor.2022.027

(Pulmonary embolism in Tábor Hospital: analysis of cohort and prevalence of pulmonary hypertension in long-term follow-up)

Jan Kuchařa, Rostislav Krála, Pavel Jansab
a Interní oddělení s kardiologickým zaměřením, Nemocnice Tábor
b II. interní klinika kardiologie a angiologie, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice Praha, Praha

Aim: The aim was to analyse the cohort of pulmonary embolism patients treated at Tábor hospital in the years 2016-2018 and to assess the prevalence and aetiology of persisting pulmonary hypertension in long-term follow-up.

Methods: The cohort of pulmonary embolism cases was analysed retrospectively. Subsequent echocardiographic examinations, performed in Tábor Hospital, were identified. Probability of pulmonary hypertension was estimated according to the ESC guidelines. The aetiology of pulmonary hypertension was evaluated retrospectively based on echocardiographic and clinical parameters found in available documentation.

Results: Total 283 cases of pulmonary embolism in 277 patients were identified (145 female, 138 male). Total 18 cases (6.4%) resulted in death. Among discharged patients, follow-up echocardiography was available in 150 patients after a median of 185 days after admission. Signs of possible pulmonary hypertension were found in 33 patients, signs of probable pulmonary hypertension in 23 patients. One patient was diagnosed with CTEPH; later, he underwent pulmonary artery endarterectomy. The diagnosis of CTEPH was probable in two patients (pulmonary hypertension, positive ventilation perfusion scan).

Conclusions: The incidence of pulmonary embolism is increasing, but its mortality is relatively low. Persisting pulmonary hypertension after acute pulmonary embolism is quite frequent, CTEPH is rare but potentially treatable complication.

Keywords: CTEPH, Pulmonary embolism, Pulmonary hypertension

Received: March 16, 2022; Revised: March 16, 2022; Accepted: March 17, 2022; Published: December 15, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kuchař J, Král R, Jansa P. (Pulmonary embolism in Tábor Hospital: analysis of cohort and prevalence of pulmonary hypertension in long-term follow-up). Cor Vasa. 2022;64(6):595-599. doi: 10.33678/cor.2022.027.
Download citation

References

  1. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020;41:543-603. Go to original source... Go to PubMed...
  2. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:1.e14-39.e14. Go to original source... Go to PubMed...
  3. https://www.czso.cz/csu/czso/pocet-obyvatel-v-obcich. Navštíveno 13. 11. 2022.
  4. Kodým M. Soubor pacientů s plicní embolií v Nemocnici Písek. Cor Vasa 2019;61:15-19. Go to original source...
  5. Keller K, Hobohm L, Ebner M, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J 2020;41:522-529. Go to original source... Go to PubMed...
  6. Dzikowska-Diduch O, Kostrubiec M, Kurnicka K, et al. The post-pulmonary syndrome - results of echocardiographic driven follow up after acute pulmonary embolism. Thromb Res 2020;186:30-35. Go to original source... Go to PubMed...
  7. Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J 2017;49:1601792. Go to original source... Go to PubMed...
  8. Coquoz N, Weilenmann D, Stolz D, et al. Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism. Eur Respir J 2018;51:1702505. Go to original source... Go to PubMed...
  9. Zhang M, Wang N, Zhai Z, et al. Incidence and risk factors of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a systematic review and meta-analysis of cohort studies. J Thorac Dis 2018;10:4751-4763. Go to original source... Go to PubMed...
  10. Yu Y, Yang L, Zhang Y, et al. Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients with diagnosis of pulmonary embolism for the first time in real world. Clin Respir J 2018;12:2551-2558. Go to original source... Go to PubMed...
  11. Boon GJAM, Ende-Verhaar YM, Bavalia R, et al. InShape II study group. Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study. Thorax 2021;76:1002-1009. Go to original source... Go to PubMed...
  12. Klok FA, Delcroix M, Bogaard HJ. Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism. J Thromb Haemost 2018;16:1040-1051. Go to original source... Go to PubMed...
  13. Ende-Verhaar YM, Meijboom LJ, Kroft LJM, et al. Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study. J Heart Lung Transplant 2019;38:731-738. Go to original source... Go to PubMed...
  14. Klok FA, Dzikowska-Diduch O, Kostrubiec M, et al. Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. J Thromb Haemost 2016;14:121-128. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.